missing translation for 'onlineSavingsMsg'
Learn More
Learn More
OPTIZYME™ M-MLV Reverse Transcriptase, Fisher BioReagents™
Click to view available options
Quantity:
25,000 U
5000 U
Unit Size:
25ku
5000 units
Description
OPTIZYME™ M-MuLV RT is a genetically modified MLV RT that possesses RNA- and DNA-dependent polymerase activity.
Applications and Features:
- OPTIZYME M-MLV RT is used for efficient first strand cDNA synthesis for RT-PCR and real-time RT-PCR (up to 13kb)
- Generation of labeled cDNA probes for microarrays
- Synthesis of cDNA for cloning and expression
- Analysis of RNA by primer extension
- DNA labeling
- Optimum activity at 42°C (active up to 50°C)
- Incorporates modified nucleotides (e.g., Cy3-, Cy5-, rhodamine-, aminoallyl-, fluorescein-labeled nucleotides)
Supplied with:
5X OPTIZYME M-MLV RT Buffer: 250mM Tris-HCl (pH 8.3 at 25°C), 250mM KCl, 20mM MgCl2, 50mM DTT
Source: E. Coli cells with a cloned fragment of the pol gene encoding Moloney Murine Leukemia Virus reverse transcriptase
Quality Control:
- Endo-, exodeoxyribonuclease, phosphatase and ribonuclease-free
- Functionally tested in first strand cDNA and RT-PCR
Specifications
Specifications
| Concentration | 200 U/μL |
| Color | Colorless |
| pH | 8.3 |
| For Use With (Application) | Generation of labeled cDNA probes for microarrays, synthesis of cDNA for cloning and expression, analysis of RNA by primer extension, DNA labeling, optimum activity at 42°C, incorporates modified Nucleotides |
| Storage Buffer | OPTIZYME™ M-MLV RT Buffer 5X : Tris HCl 250mM (8.3 pH at 25°C), KCl 250mM, MgCl2 20mM, DTT 50mM |
| Content And Storage | -20°C |
| Source | E. coli cells with a cloned fragment of the pol gene encoding Moloney Murine Leukemia Virus Reverse Transcriptase |
| Quantity | 5000 U |
| Product Type | OPTIZYME™ M-MLV Reverse Transcriptase |
| Form | Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction